Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival

Background: The outlook for patients with esophageal and gastric (EG) cancer remains poor. Hence, there is a compelling need to identify novel treatment strategies and complementary biomarkers. Programmed death ligand 1 (PD-L1) and mismatch repair deficiency (dMMR) are putative biomarkers of respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Svensson, Maria C., Borg, David, Zhang, Cheng, Hedner, Charlotta, Nodin, Björn, Uhlén, Mathias, Mardinoglu, Adil, Leandersson, Karin, Jirström, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425870/
https://www.ncbi.nlm.nih.gov/pubmed/30931254
http://dx.doi.org/10.3389/fonc.2019.00136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425870/
https://www.ncbi.nlm.nih.gov/pubmed/30931254
http://dx.doi.org/10.3389/fonc.2019.00136

Ejemplares similares